BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11261821)

  • 1. Polycythemia rubra vera versus secondary polycythemias. A clinicopathological evaluation of distinctive features in 199 patients.
    Thiele J; Kvasnicka HM; Muehlhausen K; Walter S; Zankovich R; Diehl V
    Pathol Res Pract; 2001; 197(2):77-84. PubMed ID: 11261821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Haematologica; 2001 Apr; 86(4):368-74. PubMed ID: 11325641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow features of diagnostic impact in erythrocytosis.
    Thiele J; Kvasnicka HM; Diehl V
    Ann Hematol; 2005 Jun; 84(6):362-7. PubMed ID: 15803315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of polycythemia vera based on bone marrow pathology.
    Thiele JM; Kvasnicka HM
    Curr Hematol Rep; 2005 May; 4(3):218-23. PubMed ID: 15865875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ Polyglobuly versus polycythemia vera].
    Thiele J; Kvasnicka HM
    Pathologe; 2000 Jan; 21(1):24-30. PubMed ID: 10663666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
    Michiels JJ; Juvonen E
    Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
    Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
    Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic impact of bone marrow histopathology in polycythemia vera (PV).
    Thiele J; Kvasnicka HM
    Histol Histopathol; 2005 Jan; 20(1):317-28. PubMed ID: 15578448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
    Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary (essential) thrombocythemia versus polycythemia vera rubra. A histomorphometric analysis of bone marrow features in trephine biopsies.
    Thiele J; Zankovich R; Schneider G; Kremer B; Fischer R; Diehl V
    Anal Quant Cytol Histol; 1988 Oct; 10(5):375-82. PubMed ID: 3207462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.
    Abdulkarim K; Ridell B; Johansson P; Kutti J; Safai-Kutti S; Andréasson B
    Eur J Haematol; 2011 Feb; 86(2):148-55. PubMed ID: 21059102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bone marrow in polycythemia vera.
    Ellis JT; Peterson P
    Pathol Annu; 1979; 14 Pt 1():383-403. PubMed ID: 390480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathology and histochemistry on bone marrow biopsies in chronic myeloproliferative disorders--a clue to diagnosis and classification.
    Thiele J; Kvasnicka HM
    Pathol Biol (Paris); 2001 Mar; 49(2):140-7. PubMed ID: 11317959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies.
    Ellis JT; Peterson P; Geller SA; Rappaport H
    Semin Hematol; 1986 Apr; 23(2):144-55. PubMed ID: 3704666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it justified to perform a bone marrow biopsy examination in sustained erythrocytosis?
    Thiele J; Kvasnicka HM
    Curr Hematol Malig Rep; 2006 Jun; 1(2):87-92. PubMed ID: 20425337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural, antigenetic and transcriptional characteristics in peripheral blood CD34+ progenitor cells from polycythemia vera patients: evidence for delayed determination.
    Wickenhauser C; Pérez F; Siebolts U; Lorenzen J; Varus E; Frimpong S; Thiele J
    Int J Oncol; 2003 Aug; 23(2):437-43. PubMed ID: 12851693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of the assessment of erythroid progenitors growth for differential diagnosis of primary and secondary polycythemias.
    Hansz J; Kozłowska-Skrzypczak M; Mencel P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):630-7. PubMed ID: 2448202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial (latent) polycythemia vera with thrombocytosis mimicking essential thrombocythemia.
    Thiele J; Kvasnicka HM; Diehl V
    Acta Haematol; 2005; 113(4):213-9. PubMed ID: 15983426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
    Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
    Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.